Recall alert: Tomatoes distributed in Georgia recalled due to potential salmonella contamination
Tomatoes sold under the Williams Farms Repak and the H&C Farms labels are being recalled because they may be contaminated with Salmonella.
A separate recall involves tomatoes grown by Hanshaw & Capling Farms of Immokalee, Florida.
The tomatoes were distributed between April 23 and April 28 and then packaged and sold to wholesalers and distributors in Georgia, North Carolina, and South Carolina, the FDA said.
'We are talking with the FDA trying to get a distribution list,' Craig Nielsen with the Georgia Department of Agriculture said.
Currently, the state does not know which exact stores or restaurants received shipments of the tomatoes.
TRENDING STORIES:
Gov. Kemp announces decision on Senate run in 2026, ending speculation
Police searching for grandmother, 2 young grandchildren missing in DeKalb County
'I was scared': Synthetic braiding hair linked to cancer-causing chemicals
Nielsen said inspectors will look for the products during their routine inspections.
'When our inspectors are out in the field, they are looking for the boxes that you've seen in the pictures of this product in the cases,' Nielsen said.
The tomatoes came in various packing configurations, including:
5x6, 25lb (lot code R4467)
6x6, 25lb (lot code R4467, R4470)
Combo, 25lb (lot code R4467)
4x4, 2-layer (lot code R4467)
4x5, 2-layer (lot code R4467)
60-count, 2-layer (lot code R4467)
60-count, 18lb loose (lot code R4467, R4470)
XL 18lb loose (lot code R4467)
3ct trays (lot code R4467)
Only the three-count tray has a UPC code, which is 0 33383 65504 8.
If you have the recalled tomatoes, do not consume them and return them to the place of purchase for a full refund. You can also just discard the tomatoes, the FDA said.
'The old adage of when in doubt, throw it out, certainly would apply in this situation. Don't risk your health for a few dollars of tomatoes,' Nielsen said.
No illnesses have been reported, but symptoms of a Salmonella infection can include fever, diarrhea, nausea, vomiting, and abdominal pain. In some rare cases, the organism can get into the bloodstream and cause arterial infections, endocarditis, and arthritis.
'Food poisoning does not alter the color, look, or taste of food so it's hard to identify until it is too late,' Dr. Danny Branstetter with WellStar Health System said.
Branstetter said you can reduce your risk by properly washing and cooking the food in question.
If you have questions, contact the company at 843-866-7707 or 843-599-5154, Monday through Friday from 8 a.m. to 5 p.m. ET.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
an hour ago
- Medscape
Part D Cancer Drug Launch Prices Soar Past Inflation
Launch prices for Medicare Part D anticancer drugs have risen sharply since 2012, with a mean increase of $1694 per year. In 2025, the observed prices were 15%-200% higher than expected if the increases were due to inflation alone, but the gap between observed and inflation-adjusted prices narrowed over the study period. METHODOLOGY: The Inflation Reduction Act of 2022 introduced price negotiation for Medicare-covered drugs and required manufacturers to pay rebates to Medicare for price increases above inflation. But it did not address the launch prices of new drugs. Anticancer drugs, a protected drug class with mandatory Medicare Part D coverage, may now be especially prone to higher launch prices, in part because the Inflation Reduction Act limits out-of-pocket spending and price increases after market entry. Researchers identified 86 branded, self-administered, molecularly targeted anticancer therapies approved by the FDA between January 2010 and December 2024. Data on drug prices were obtained from the Medicare Prescription Drug Plan Formulary and adjusted for inflation. The researchers looked at launch prices by year and compared drug prices in 2025 with those expected if launch prices had increased due to inflation alone since the drug's market entry. TAKEAWAY: The mean monthly launch price increased from $10,954 for drugs first observed in the Medicare formulary in 2012-2014 to $27,891 for drugs first observed in 2023-2025. After adjusting for inflation, the mean launch price increased by $1694 per year ( P < .001). < .001). In 2025, actual drug prices were 14.8%-200.9% higher than expected if they had only kept pace with inflation. Although the gap between observed and inflation-adjusted prices narrowed over time, price increases continued to outpace inflation in 2023 and 2024, despite the Inflation Reduction Act rebate requirement, which will result in rebates to Medicare starting in fall 2025. IN PRACTICE: 'Launch prices for self-administered targeted anticancer therapies have grown precipitously, although no evidence was found of disproportionate increases in recent years. Instead, continued launch price growth for anticancer therapies was observed, consistent with prior research,' the study authors wrote. 'This suggests that companies were already engaging in price maximization for anticancer therapies and continued to do so after the implementation of the [Inflation Reduction Act].' SOURCE: This study, led by Stacie B. Dusetzina, PhD, Vanderbilt University School of Medicine in Nashville, Tennessee, was published online in JAMA . LIMITATIONS: This study used example indications to determine monthly doses and pricing. Additionally, variations in available price measures were noted over the study period. DISCLOSURES: This study was funded by Arnold Ventures. Several authors reported receiving grants or personal fees and having other ties with various sources.
Yahoo
3 hours ago
- Yahoo
COVID Crusader Writes Open Letter To RFK Jr On mRNA
A prominent group of health activists is threatening a political revolt against HHS Secretary Robert F. Kennedy Jr. over what they call a betrayal of their movement's central cause. In a blistering open letter dated June 4, COVID crusader Dr. Mary Talley Bowden and several allies from the MAHA (Make America Healthy Again) movement — a grassroots coalition of vaccine-critical and medical freedom activists — accused Kennedy and FDA Commissioner Dr. Marty Makary of watering down policies related to the controversial mRNA vaccine platform, especially in guidance affecting children and pregnant women. 'We did not fight for you to be in positions of leadership so that our clearly stated policy goals would suffer a 'bait and switch,'' Bowden wrote, warning Kennedy that MAHA voters 'can walk away' if their demands are not met. The letter criticizes recent CDC and FDA policy changes, calling them deceptive and insufficient, and claims the administration is engaging in 'linguistic misdirections' to hide the continued recommendation of mRNA shots for vulnerable populations. The MAHA letter insists the mRNA platform — particularly COVID vaccines — should be pulled from the market entirely, citing adverse event data and peer-reviewed studies. It demands sweeping reforms: a full ban on mRNA technologies, repeal of the PREP Act, elimination of vaccine-related conflicts of interest in federal agencies, and an end to direct-to-consumer pharmaceutical advertising. The signatories include author Naomi Wolf, podcaster Shannon Joy, and several other activists who rose to prominence during the COVID-19 pandemic by challenging government vaccine narratives. The backlash comes amid growing scrutiny of RFK Jr.'s recent actions as HHS secretary. Once one the nation's most vocal mRNA vaccine skeptic, Kennedy has walked a careful line in office, telling Congress in May that his personal views on vaccines are 'irrelevant' and vowing not to make sudden changes to CDC policy. 'I don't think people should be taking medical advice from me,' Kennedy told lawmakers, as reported by The Hill on June 2. Still, his critics on both sides see Kennedy's recent moves as consequential. Late last month, he released a 58-second video on X stating that COVID vaccines for healthy children and healthy pregnant women had been removed from the CDC's immunization schedule — a declaration Bowden and others say was misleading. Indeed, as The Hill previously reported, the CDC quietly changed its guidance to say healthy children may receive the COVID vaccine after consultation with a healthcare provider, while maintaining stronger recommendations for other vulnerable categories. For pregnant women, the recommendation was similarly softened but not eliminated, and pregnancy remains classified by the FDA as a high-risk health condition, allowing continued vaccine use under certain circumstances. Bowden's letter zeroes in on this ambiguity, arguing that wordplay is being used to sustain vaccine availability under the appearance of reform. 'Pregnant women have not been made any safer by your wordplay,' she writes, warning that MAHA activists are prepared to run their own candidates in upcoming elections if their demands are ignored. The political threat underscores the friction between Kennedy and the movement that once celebrated his nomination. While Kennedy has taken steps to reshape HHS in ways consistent with his skepticism — including canceling hundreds of millions of dollars in funding for Moderna's mRNA flu vaccine— his first few months of actions have not thus far rendered the swift action that some would have hoped. Former CDC acting director Dr. Richard Besser and other public health experts have voiced alarm at Kennedy's willingness to circumvent the CDC's vaccine advisory panel, which has traditionally guided immunization policy through public, evidence-based deliberation. 'We're seeing a total side-stepping of the nation's leading public health agency,' Besser told The Hill. The vaccine panel has not yet weighed in on the updated COVID shot guidance. Its next meeting is scheduled for late June, and observers expect tense debate over whether Kennedy's changes represent science-based reform or political overreach. In the meantime, Bowden's warning reflects the fragile coalition Kennedy is attempting to hold together. The MAHA movement — built in part from disaffected MAGA voters, vaccine skeptics, and parents concerned about government overreach — played a pivotal role in rallying support for Kennedy's confirmation and the broader medical freedom agenda. Now, its leaders are openly questioning whether Kennedy's tenure will deliver the systemic change they demand — or whether they were simply used to fuel a political ascent. 'MAHA is not the possession of Secretary Kennedy,' Bowden wrote. 'It is the voice of millions of desperate parents… and their activism will outlast any administration.' The Dallas Express reached out to HHS but did not immediately receive a response. Kennedy previously spoke to The Dallas Express about a lawsuit Bowden brought against the FDA for misleading the public about using ivermectin for the treatment of COVID-19 during his presidential campaign in 2024 and just after the FDA settled the case. 'All three of the principal health agencies [CDC, NIH, FDA] suffer from agency capture,' Kennedy said. 'I would say 50% of the FDA's budget is from pharmaceutical companies. NIH scientists are allowed to collect royalties on drugs that they regulate –– which is clearly a conflict of interest. CDC … has devolved into an agency that primarily promotes the mercantile interests of the pharmaceutical companies.' He told DX that the agencies are overly influenced by perverse incentives from the pharmaceutical industry and added, 'I will change those incentives and unravel the culture of corruption that now has turned these agencies against public health.'
Yahoo
4 hours ago
- Yahoo
1.7 Million Cartons of Eggs Recalled for Salmonella Contamination
On June 6, the United States Food & Drug Administration (FDA) announced that August Egg Company of Hilmar, CA, is recalling 1.7 million dozen cage-free and certified organic eggs. The brown eggs, which were distributed in at least nine states, have been linked to a salmonella outbreak. According to the Centers for Disease Control & Prevention (CDC), there have been 79 reported salmonella infections so far, with 21 of those people being Name: Various brands of cage-free and organic eggs Date of Recall: June 6, 2025 Plant Code Number: P-6562 or CA5330 Distribution: Arizona, California, Illinois, Indiana, Nebraska, New Mexico, Nevada, Washington, WyomingSalmonella can cause severe gastrointestinal symptoms, such as stomach cramps, diarrhea, and fever. The symptoms of salmonella can start anywhere from six hours after eating contaminated food to six days after exposure. The recalled eggs were distributed in California and Nevada from February 3, 2025 to May 15, 2025 with sell by dates of March 4, 2025 to June 4, 2025, The eggs were sold at grocers including Save Mart, FoodMaxx, Lucky, Smart & Final, Safeway, Raleys, Food 4 Less, and Ralphs. The eggs were also distributed in Walmart stores from February 3, 2025 to May 6, 2025 with sell-by dates from March 4, 2025 to June 19, 2025. Walmarts in California, Washington, Nevada, Arizona, Wyoming, New Mexico, Nebraska, Indiana, and Illinois sold the recalled eggs. This recall affects numerous brands of eggs, including Simply Truth Organic, which is sold at Kroger stores, and Marketside, which is sold at Walmart. Check for a full list of brands affected by the recall. If you have one of the affected cartons of eggs in your fridge, do not eat them. Instead, the FDA recommends returning the eggs to your place of purchase for a refund. If you have questions about this recall, contact August Egg Company at 1-800-710-2554, between 9 a.m. and 5 p.m. PT. Read the original article on SIMPLYRECIPES
